scispace - formally typeset
R

Robert A. Rosenheck

Researcher at Yale University

Publications -  993
Citations -  58354

Robert A. Rosenheck is an academic researcher from Yale University. The author has contributed to research in topics: Mental health & Veterans Affairs. The author has an hindex of 114, co-authored 963 publications receiving 54357 citations. Previous affiliations of Robert A. Rosenheck include Eastern Virginia Medical School & The Feinstein Institute for Medical Research.

Papers
More filters
Journal ArticleDOI

Obesity among chronically homeless adults: is it a problem?

Jack Tsai, +2 more
- 01 Jan 2013 - 
TL;DR: Findings underscore the need for greater attention to obesity in chronically homeless adults and demonstrate a food insecurity-obesity paradox or poverty-ob obesity link.
Journal ArticleDOI

A National Survey of the Oral Health Status of Homeless Veterans

Gretchen Gibson, +7 more
- 01 Mar 2003 - 
TL;DR: As expected, the homeless veterans exhibited poor oral health, but it was not different from domiciled veterans enrolled in substance addiction programs, and two remarkably similar populations were described.
Journal ArticleDOI

An assessment of attitudes towards people with mental illness among medical students and physicians in Ibadan, Nigeria.

Adesuwa Ighodaro, +3 more
- 01 Jun 2015 - 
TL;DR: While beliefs about medication effectiveness do not differ between medical trainees and graduate professionals, stigmatizing attitudes towards people with mental illness seem to be most strongly affected by clinical training.
Journal ArticleDOI

Joint modelling of longitudinal outcome and interval-censored competing risk dropout in a schizophrenia clinical trial

Ralitza Gueorguieva, +2 more
- 01 Apr 2012 - 
TL;DR: A joint model for the longitudinal outcome and cause-specific dropouts that allows for interval-censored dropout times is constructed and incorporating the information regarding the cause of dropout improves inferences and provides better understanding of the association between cause- specific dropout and the outcome process.
Journal ArticleDOI

Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.

Donald Addington, +7 more
- 01 Jan 2011 - 
TL;DR: A signal indicating a small potential difference favoring quetiapine over risperidone only in patients with an MDE at baseline was detected, but there was a significant improvement in depression across all treatments.